PhaseV

PhaseV is a Boston-based technology company transforming clinical development with advanced causal machine learning, GenAI, and real-world data. Its AI-powered platform helps biopharma sponsors and CROs design and optimize adaptive, Bayesian, and fixed-design trials, identify treatment-responsive patient subgroups and biomarkers, strengthen site selection and clinical operations, and make faster, evidence-driven decisions. By translating complex clinical data into actionable insights, PhaseV helps reduce trial risk, timelines, and costs while increasing the probability of success and accelerating new therapies to patients.